Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2011, Article ID 581372, 11 pages
http://dx.doi.org/10.1155/2011/581372
Research Article

Utility of N-Bromosuccinimide for the Titrimetric and Spectrophotometric Determination of Famotidine in Pharmaceutical Formulations

Department of Chemistry, University of Mysore, Manasagangothri, Mysore 570 006, India

Received 15 January 2011; Accepted 23 March 2011

Academic Editor: Bogusław Buszewski

Copyright © 2011 O. Zenita and K. Basavaiah. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. British Pharmacopoeia, The Stationary Office London, 1998.
  2. U. S. Pharmacopoeia 30, National Formulary 35, U. S. Pharmacopoeial Convention, Rockville, Md, USA, 2007.
  3. S. E. Biffar and D. J. Mazzo, “Reversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase,” Journal of Chromatography, vol. 363, no. 2, pp. 243–249, 1986. View at Google Scholar · View at Scopus
  4. A. Mutaz, S. Sheikh, A. N. Hanan, and B. A. Adnan, “High pressure liquid chromatographic analysis and dissolution of famotidine in tablet formulation,” Analytical Letters, vol. 22, no. 11&12, pp. 2501–2510, 1989. View at Google Scholar
  5. C. Ho, H. M. Huang, S. Y. Hsu, C. Y. Shaw, and B. L. Chang, “Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products,” Drug Development and Industrial Pharmacy, vol. 25, no. 3, pp. 379–385, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Novaković, “High-performance thin-layer chromatography for the determination of ranitidine hydrochloride and famotidine in pharmaceuticals,” Journal of Chromatography A, vol. 846, no. 1-2, pp. 193–198, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. N. Campbell and J. Sherma, “Determination of famotidine in acid reduction tablets by HPTLC and videodensitometry of fluorescence quenched zones,” Journal of Liquid Chromatography and Related Technologies, vol. 26, no. 16, pp. 2719–2727, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Wu, Y. U. H. Ho, H. L. Wu, S. U. H. Chen, and H. S. Ko, “Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis,” Electrophoresis, vol. 22, no. 13, pp. 2758–2762, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Ayad, A. Shalaby, H. E. Abdellatef, and H. M. Elsaid, “Potentiometric determination of famotidine in pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 1-2, pp. 247–254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Squella, C. Rivera, I. Lemus, and L. J. Nuñez-Vergara, “Differential pulse voltammetric determination of famotidine,” Mikrochimica Acta, vol. 100, no. 5-6, pp. 343–348, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. M. I. Walash, A. El-Brashy, N. El-Enany, and M. E. Kamel, “Spectrofluorimetric determination of famotidine in pharmaceutical preparations and biological fluids. Application to stability studies,” Journal of Fluorescence, vol. 19, no. 2, pp. 333–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ael-Bayoumi, A. A. El-Shanawany, M. E. El-Sadek, and A. Abd El-Sattar, “Synchronous spectrofluorimetric determination of famotidine, fluconazole and ketoconazole in bulk powder and in pharmaceutical dosage forms,” Spectroscopy Letters, vol. 30, no. 1, pp. 25–46, 1997. View at Google Scholar · View at Scopus
  13. M. I. Walash, M. K. Sharaf-El-Din, M. E. S. Metwally, and M. R. Shabana, “Polarographic determination of famotidine through complexation with Nickel(II)chloride,” Journal of the Chinese Chemical Society, vol. 52, no. 5, pp. 927–935, 2005. View at Google Scholar · View at Scopus
  14. M. Apostu, N. Bibire, and V. Dorneanu, “UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinateDeterminarea cantitativa spectrofotometrica in uv a famotidinei sub forma de picrolonat,” Revista Medico-Chirurgicală a Societăţii de Medici şi Naturalişti din Iaşi, vol. 109, no. 2, pp. 422–425, 2005. View at Google Scholar · View at Scopus
  15. K. Basavaiah and H. C. Prameela, “Titrimetric and spectrophotometric determination of famotidine using chloramine-T,” Bulgarian Chemical Communications, vol. 35, no. 1, pp. 37–42, 2003. View at Google Scholar
  16. K. Basavaiah and H. C. Prameela, “Four simple methods for the determination of famotidine in bulk form and formulations,” Bulgaria Chemical Industry, vol. 74, no. 2, pp. 50–55, 2003. View at Google Scholar
  17. A. Z. Abu Zuhri, R. M. Shubietah, and G. M. Badah, “Extractional-spectrophotometric determination of famotidine in pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 2, pp. 459–465, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. B. V. Kamath, K. Shivram, and V. Saroj, “Spectrophotometry determination of famotidine by charge transfer complexation,” Analytical Letters, vol. 25, no. 12, pp. 2239–2247, 1992. View at Google Scholar
  19. S. Al-Ghannam and F. Belal, “Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation,” Journal of AOAC International, vol. 85, no. 5, pp. 1003–1008, 2002. View at Google Scholar · View at Scopus
  20. B. K. C. Chukwurah and U. Ajali, “Quantitative determination of famotidine through charge-transfer complexation with chloranilic acid,” Bollettino Chimico Farmaceutico, vol. 140, no. 5, pp. 354–360, 2001. View at Google Scholar · View at Scopus
  21. H. A. Mohammad, “Spectrophotometric determination of famotidine using p-chloranilic acid,” Bulletin of Pharmaceutical Sciences (Assiut University), vol. 23, pp. 157–163, 2000. View at Google Scholar
  22. K. Basavaiah and H. C. Prameela, “Spectrophotometric determination of famotidine in pharmaceutical preparations,” Industrial Pharmacy, vol. 3, no. 20, pp. 59–61, 2004. View at Google Scholar
  23. B. Guvener and S. Ates, “Method for the assay of famotidine,” Acta Pharmaceutica Turcica, vol. 30, pp. 67–68, 1998. View at Google Scholar
  24. Z. Korićanac, T. Jovanović, J. Petković, and D. Minić, “Spectrophotometric investigation of famotidine-Pd(II) complex and its analytical application in drug analysis,” Journal of the Serbian Chemical Society, vol. 69, no. 6, pp. 485–491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Rahman and M. Kashif, “Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations,” IL Farmaco, vol. 58, no. 10, pp. 1045–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. K. Agrawal, K. Shivramchandra, G. N. Singh, and B. E. Rao, “Spectrophotometric determination of famotidine in pharmaceutical preparations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 10, no. 7, pp. 521–523, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. N. R. Reddy, K. Prabhavathi, Y. V. B. Reddy, and I. E. Chakravarthy, “A new spectrophotometric determination of famotidine from tablets,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 5, pp. 645–647, 2006. View at Google Scholar · View at Scopus
  28. G. R. Rao, G. Kanjilal, and K. R. Mohan, “Extended application of folin-ciocalteu reagent in the determination of drugs,” The Analyst, vol. 103, no. 1230, pp. 993–994, 1978. View at Google Scholar · View at Scopus
  29. M. M. Ayad, A. Shalaby, H. E. Abdellatef, and M. M. Hosny, “New colorimetric methods for the determination of trazodone HCl, famotidine, and diltiazem HCl in their pharmaceutical dosage forms,” Analytical and Bioanalytical Chemistry, vol. 376, no. 5, pp. 710–714, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Ibrahim, A. Darwish Samiha, M. Hussein Ashraf, and I. Mahmoud Ahmed Hassan, “Sensitive spectrophotometric method for the determination of H2-receptor antagonists by means of N-bromosuccinimide and p-aminophenol,” International Journal of Biomedical Science, vol. 3, no. 2, pp. 123–130, 2007. View at Google Scholar
  31. A. Berka, J. Vulterin, and J. Zyoka, Newer Redox Titrants, Pargamon Press, New York, NY, USA, 1965.
  32. R. N. J. Kucharsky and L. Safarik, Titrations in Non-Aqueous Solvents, Elsevier, Amsterdam, The Netherlands, 1965.
  33. J. D. Morrison and R. N. Boyd, Organic Chemistry, Prentice Hall, New York, NY, USA, 6th edition, 1992.
  34. ICH Steering Committe, “ICH harmonised tripartite guideline, validation of analytical procedures: text and methodology Q2(R 1),” in Proceedings of the International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, London, UK, November 1996.
  35. J. March, Oxidations and Reductions. In advanced Organic Chemistry-Reactions, Mechanisms, and Structure, John Wiley & Sons, Singapore, 4th edition, 2006.
  36. B. M. Trost and D. P. Curran, “Chemoselective oxidation of sulfides to sulfones with potassium hydrogen persulfate,” Tetrahedron Letters, vol. 22, no. 14, pp. 1287–1290, 1981. View at Google Scholar · View at Scopus
  37. http://www.inchem.org/documents/jecfa/jecmono/v50je12.htm.
  38. http://www.answers.com/topic/thiazole.
  39. D. Cairns, Essentials of Pharmaceutical Chemistry, Pharmaceutical Press, Cornwall, UK, 3rd edition, 2008.